Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

BACKGROUND: Little is known about the distribution of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) to patients participating in state medical cannabis programs. The Minnesota cannabis program requires third-party testing of products with limited formulations of cannabis for distribution to pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Xintian, Illamola, Sílvia M., Marino, Susan E., Leppik, Ilo E., Dahmer, Stephen, Lehfeldt, Paloma, Conway, Jeannine M., Remmel, Rory P., Kingsley, Kyle, Birnbaum, Angela K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393751/
https://www.ncbi.nlm.nih.gov/pubmed/37538850
http://dx.doi.org/10.1016/j.curtheres.2023.100709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393751/
https://www.ncbi.nlm.nih.gov/pubmed/37538850
http://dx.doi.org/10.1016/j.curtheres.2023.100709

Ejemplares similares